OraSure Technologies Inc (NAS:OSUR)
$ 3.62 -0.09 (-2.43%) Market Cap: 270.03 Mil Enterprise Value: 2.57 Mil PE Ratio: 24.13 PB Ratio: 0.63 GF Score: 69/100
Back to the Transcripts List

Q3 2024 OraSure Technologies Inc Earnings Call Transcript

Nov 06, 2024 / 10:00PM GMT
Release Date Price: $4.4 (+2.56%)

Key Points

Positve
  • OraSure Technologies Inc (OSUR) delivered Q3 revenue in the top half of their guidance ranges for core and total revenue.
  • The company received initial international orders for the OraQuick HCV Self-test following WHO prequalification, marking a significant milestone.
  • OraSure Technologies Inc (OSUR) generated $12.7 million of operating cash flow during Q3, indicating strong cash management.
  • The company is expanding its sample management portfolio with a planned launch targeting the blood proteomics market in 2025.
  • OraSure Technologies Inc (OSUR) is making progress in operational efficiency by in-sourcing production to improve gross margins.
Negative
  • Core revenue decreased by 1% year-over-year in Q3, impacted by a decline in the risk assessment testing business.
  • The risk assessment testing business, which is being exited, has become slightly unprofitable.
  • Sample Management revenue decreased 16% year-over-year, indicating challenges in this segment.
  • The international business, while growing, carries lower gross margins than the corporate average, impacting overall profitability.
  • The company is facing gross margin headwinds due to the winding down of the risk assessment business and elevated costs.
Operator

Good day, and thank you for standing by. Welcome to the OraSure Technologies, Inc. 2024 Third Quarter earnings conference call. (Operator Instructions). Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, Jason Plagman, Vice President of Investor Relations. Please go ahead.

Jason Plagman
OraSure Technologies Inc - Vice President, Investor Relations

Good afternoon, and welcome to OraSure Technologies' Third Quarter 2024 earnings call. Participating in the call today for OTI are Carrie Eglinton Manner, our President and Chief Executive Officer; and Ken McGrath, our Chief Financial Officer.

As a reminder, today's webcast is being recorded, and the recording can be found on our Investor Relations website. Before we begin, you should know that this call may contain certain forward-looking statements, including statements with respect to revenues, expenses, profitability, earnings or loss per share and other financial performance, product development, performance,

Already have an account? Log in
Get the full story
Start 7-Day Free Trial
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.